Key Takeaways
- The UK government aims to restore the NHS standard of treating 92% of patients within 18 weeks of referral by March 2029, including those awaiting ophthalmology care
- Planned reforms include standardized glaucoma pathways, improved referral technology, expanded ophthalmic surgical hubs, and home-based glaucoma services through NHS Online
The UK government has outlined a series of initiatives intended to reduce ophthalmology waiting times, address regional disparities, and move more eye care into community and digital settings.
The measures were detailed in a written parliamentary response published August 25, following a question from Baroness Redfern about plans to publish ophthalmology waiting-time data and address inconsistent commissioning of sight-saving treatment across England.
Baroness Merron, parliamentary under-secretary of state for health and social care, said the government remains committed to restoring the NHS constitutional standard under which 92% of patients begin consultant-led treatment within 18 weeks of referral by March 2029.
Across all medical specialties, the proportion of patients waiting less than 18 weeks increased from 65.7% in July 2024 to 74.1% in May 2026, according to the response. The government did not provide a separate national percentage for ophthalmology.
Several initiatives are being implemented specifically to improve eye care services. NHS England accelerator pilot programs have demonstrated that better information technology connectivity and a single point of access can accelerate referrals and allow more patients to be managed in community settings, the government said.
NHS England’s "Getting It Right First Time" program also released best-practice guidance for glaucoma care in May 2026. The document is expected to be the first in a series covering ophthalmic conditions and is intended to standardize patient pathways across England.
According to the government, greater pathway consistency should help ophthalmology teams identify and prioritize patients with the most complex conditions or the greatest risk of vision loss.
The response also highlighted the planned introduction of NHS Online in 2027. Patients participating in glaucoma pathways are expected to have the option of receiving certain elements of specialist care from home. Across all specialties, NHS Online is projected to deliver the equivalent of as many as 8.5 million appointments and assessments during its first 3 years.
The government also plans to expand surgical hubs, which provide protected capacity for elective procedures. Ophthalmology is one of six specialties targeted by that initiative. To address geographic variations in access and outcomes, commissioners will continue to receive data through the Public Health Outcomes Framework eye-health indicator. The measure tracks sight loss associated with age-related macular degeneration, glaucoma, and diabetic retinopathy.
The government noted that integrated care boards are legally required to fund medicines recommended by the National Institute for Health and Care Excellence, including approved treatments for ophthalmic conditions such as age-related macular degeneration.
The parliamentary response did not announce a new ophthalmology-specific waiting-time publication. However, it pointed to existing NHS data and described a broader strategy centered on digital access, community-based care, standardized pathways, and expanded surgical capacity.
